Accenture Plc (NYSE:ACN) Shares Acquired by Zurich Insurance Group Ltd FI

Share on StockTwits

Zurich Insurance Group Ltd FI grew its holdings in Accenture Plc (NYSE:ACN) by 19.5% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 180,168 shares of the information technology services provider’s stock after buying an additional 29,373 shares during the period. Zurich Insurance Group Ltd FI’s holdings in Accenture were worth $33,290,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of ACN. Private Trust Co. NA boosted its stake in shares of Accenture by 1.6% in the second quarter. Private Trust Co. NA now owns 3,642 shares of the information technology services provider’s stock valued at $672,000 after purchasing an additional 57 shares during the period. Modera Wealth Management LLC lifted its stake in Accenture by 1.5% in the second quarter. Modera Wealth Management LLC now owns 3,891 shares of the information technology services provider’s stock worth $719,000 after acquiring an additional 57 shares during the last quarter. Enterprise Bank & Trust Co lifted its stake in Accenture by 0.7% in the second quarter. Enterprise Bank & Trust Co now owns 9,780 shares of the information technology services provider’s stock worth $1,807,000 after acquiring an additional 65 shares during the last quarter. Tarbox Family Office Inc. raised its holdings in Accenture by 34.6% during the second quarter. Tarbox Family Office Inc. now owns 253 shares of the information technology services provider’s stock worth $47,000 after purchasing an additional 65 shares in the last quarter. Finally, Highland Private Wealth Management raised its holdings in Accenture by 4.8% during the second quarter. Highland Private Wealth Management now owns 1,446 shares of the information technology services provider’s stock worth $268,000 after purchasing an additional 66 shares in the last quarter. Institutional investors and hedge funds own 69.84% of the company’s stock.

A number of analysts have weighed in on the stock. Deutsche Bank raised their price objective on shares of Accenture from $180.00 to $190.00 and gave the stock a “buy” rating in a report on Monday, June 10th. UBS Group set a $190.00 target price on shares of Accenture and gave the company a “hold” rating in a report on Friday, June 28th. Credit Suisse Group set a $180.00 target price on shares of Accenture and gave the company a “hold” rating in a report on Friday, June 28th. Citigroup lifted their target price on shares of Accenture from $194.00 to $211.00 and gave the company a “buy” rating in a report on Thursday, June 20th. Finally, Barclays initiated coverage on shares of Accenture in a report on Friday. They issued an “overweight” rating and a $228.00 target price on the stock. One research analyst has rated the stock with a sell rating, five have given a hold rating and thirteen have assigned a buy rating to the stock. Accenture currently has an average rating of “Buy” and a consensus price target of $199.06.

In related news, General Counsel Chad T. Jerdee sold 3,247 shares of the stock in a transaction that occurred on Monday, July 1st. The shares were sold at an average price of $186.34, for a total transaction of $605,045.98. Following the completion of the sale, the general counsel now owns 13,271 shares of the company’s stock, valued at approximately $2,472,918.14. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO David Rowland sold 2,255 shares of the stock in a transaction that occurred on Tuesday, July 16th. The stock was sold at an average price of $194.03, for a total transaction of $437,537.65. Following the sale, the chief executive officer now directly owns 25,078 shares of the company’s stock, valued at approximately $4,865,884.34. The disclosure for this sale can be found here. Insiders sold a total of 22,760 shares of company stock valued at $4,353,328 in the last three months. 0.18% of the stock is currently owned by corporate insiders.

Shares of Accenture stock traded down $1.28 on Friday, hitting $193.39. The company’s stock had a trading volume of 47,677 shares, compared to its average volume of 1,771,012. Accenture Plc has a 52-week low of $132.63 and a 52-week high of $202.80. The firm has a fifty day moving average price of $194.25 and a 200-day moving average price of $183.41. The company has a market capitalization of $130.81 billion, a P/E ratio of 28.70, a price-to-earnings-growth ratio of 2.37 and a beta of 1.04.

Accenture (NYSE:ACN) last released its quarterly earnings data on Thursday, June 27th. The information technology services provider reported $1.93 EPS for the quarter, topping the consensus estimate of $1.89 by $0.04. Accenture had a net margin of 10.93% and a return on equity of 36.24%. The business had revenue of $11.10 billion for the quarter, compared to analyst estimates of $11.03 billion. During the same period in the previous year, the firm earned $1.79 EPS. The business’s revenue for the quarter was up 3.8% compared to the same quarter last year. As a group, analysts expect that Accenture Plc will post 7.33 earnings per share for the current year.

Accenture Company Profile

Accenture plc provides consulting, technology, and outsourcing services in Ireland and internationally. Its Communications, Media & Technology segment provides professional services that help clients accelerate and deliver digital transformation, develop industry-specific solutions, and enhance efficiencies and business results for communications, media, high tech, software, and platform companies.

Read More: Quantitative Easing

Want to see what other hedge funds are holding ACN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Accenture Plc (NYSE:ACN).

Institutional Ownership by Quarter for Accenture (NYSE:ACN)

Receive News & Ratings for Accenture Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accenture and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Investment Analysts’ Price Target Changes for October, 14th
Investment Analysts’ Price Target Changes for October, 14th
Civic  Market Cap Achieves $26.92 Million
Civic Market Cap Achieves $26.92 Million
TRAXIA Tops 24-Hour Trading Volume of $207.00
TRAXIA Tops 24-Hour Trading Volume of $207.00
TOP  Price Hits $0.0022
TOP Price Hits $0.0022
Syndax Pharmaceuticals  Stock Rating Upgraded by Zacks Investment Research
Syndax Pharmaceuticals Stock Rating Upgraded by Zacks Investment Research
Laboratory Corp. of America  Stock Rating Upgraded by Zacks Investment Research
Laboratory Corp. of America Stock Rating Upgraded by Zacks Investment Research


 
© 2006-2019 Zolmax.